Investigating differential responses based on patient demographics, genetic profiles, and specific pain conditions will also be crucial in developing personalized treatment strategies, thereby optimizing the therapeutic benefits of GLP-1R agonists for diverse patient populations
The longest published trial data covers up to 84 weeks
Compounded medications are customized pharmaceutical products offered as an alternative to FDA approved medications and may contain FDA approved ingredients but are not themselves FDA approved
Document GI effects, abdominal pain, and signs of pancreatitis or gallbladder disease, and assess hypoglycemia risk if insulin or a sulfonylurea is on board
Blood sugar changes are one possible explanation, but further research in humans is needed to confirm this
Thus, GLP-1 RAs are considered effective in promoting insulin secretion and inhibiting glucagon secretion by targeting most of the defects associated with the pathogenesis of T2DM [16]